We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Hikma Pharmaceuticals plc (PK) | USOTC:HKMPY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 49.00 | 46.76 | 51.82 | 96 | 21:01:20 |
From Jul 2019 to Jul 2024
By Ian Walker
LONDON--Speciality chemicals company Hikma Pharmaceuticals PLC (HIK.LN) is expected to be promoted to the FTSE100 index for the first time since it floated in 2005 replacing oil company Tullow Oil PLC (TLW.LN), in the latest quarterly reshuffle, based on indicative data from FTSE International Monday.
Hikma was founded in Amman, Jordan in 1978 by its current chairman, Mr. Samih Darwazah. It has over 825 products in its portfolio, across all regions and markets. Tullow, an independent oil and gas exploration and production group, has been a member of the top-flight index since September 2007.
The changes will be based on Tuesday's closing share prices and take effect from close of business March 20.
The FTSE100 is a share index of the 100 most highly-capitalized companies listed on the London Stock Exchange. Any company that falls to 111th and below is automatically ejected from the index, while any firm that rises to 90 or above is automatically promoted.
-Write to Ian Walker at ian.walker@wsj.com
1 Year Hikma Pharmaceuticals (PK) Chart |
1 Month Hikma Pharmaceuticals (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
